Hemodynamic effects of recombinant human erythropoietin

Nephron

Volumn 81, Issue 1, 1999, Pages 1-4

  Buemi, Michele ^a   Allegra, Alessandro ^a   Aloisi, Carmela ^a   Corica, Francesco ^a   Frisina, Nicola ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; NITRIC OXIDE; PHENYLEPHRINE; RECOMBINANT ERYTHROPOIETIN;

BOLUS INJECTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DOSE RESPONSE; HEART INDEX; HEMODYNAMICS; HEMORRHAGIC SHOCK; HUMAN; HYPERTENSION; HYPOVOLEMIC SHOCK; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; ERYTHROPOIETIN, RECOMBINANT; HEMODYNAMIC PROCESSES; HUMANS;

EID: 0032921143     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045238     Document Type: Short Survey

References (21)

1. Krantz SB: Erythropoietin. Blood 1991;77: 419-434.
2. Buemi M, Allegra A, Frisina N: Eritropoietina: Non solo anemia renale. G Ital Nefrol 1995;12: 9-15.
3. Maschio G: Erythropoietin and systemic hypertension. Nephrol Dial Transplant 1995; 10(suppl 2):74-79.
4. Raine AEG: Hypertension, blood viscosity and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy. Lancet 1988;i:97-100.
5. Mayer G, Stefanelli TH, Cada EM: Blood pressure and erythropoietin. Lancet 1988;ii:13.
6. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990;87:5978-5982.
7. Ammarguellat F, Gogusev J, Drucke TB: Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 1996;11: 687-692.
8. Heindenreich S, Rahan KH, Zidek W: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991;39:259-265.
9. Buemi M, Allegra A, Marino D, Aloisi C, Baldari S, Privitera M, Vitulo F, Morabito N, Buemi AL, Bonanno N, Frisina N: Eritropoietina ricombinante ed ipertensione arteriosa. G Ital Nefrol 1991;8:155-160.
10. Lefer AM, Spath JA: Pharmacologic basis of the treatment of circulatory shock; in Antonaccio M (ed): Cardiovascular Pharmacol, ed 2. New York, Raven Press, 1984, pp 535-577.
11. Rockett KA, Awburn MA, Aggarwal BB, et al: In vivo induction of nitrite/nitrate by TNF, LT and IL-1: roles in malaria. Infect Immunity, 1992;60:3725-3730.
12. Buermi M, Allegra A, Squadrito F, Buemi AL, Lagana A, Aloisi C, Frisina N: Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock. Nephron 1993;65:440-443.
13. Allegra A, Galasso G, Siracusano L, Aloisi C, Corica F, Frisina N, Buemi M: Effects of i.v. administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock. Nephron 1996;74:431-432.
14. + flow into the red blood cells in normotensive and hypertensive subjects. Nephron 1991;59: 343-344.
15. Miller VM, Vanhoutte PM: Endothelium-dependent responses and their potential relevance to the distribution of blood flow during hemorrhagic shock. Resuscitation 1989;89:5-71.
16. Szabo C, Thiemermann C: Invited opinion: role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and thermal injury. Shock 1994;2:145-155.
17. Martin J, Moncada S: Blood pressure, erythropoietin and nitric oxide. Lancet 1988;i:644.
18. Del Castillo D, Raij L, Shultz PJ, Tolins JP: The presser effect of recombinant human erythropoietin is not due to decreased activity of the endogenous nitric oxide system. Nephrol Dial Transplant 1995;10:505-508.
19. Buemi M, Denuzzo G, Allegra A, Aloisi C, Squadrito F, Squadrito G, Dattola A, Corica F, Vermiglio G: Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine. Int J Microcirc 1995; 15:283-286.
20. Buemi M, Morabito N, Palella S, et al: Influence of recombinant erythropoietin on the production of endothelin from human umbilical artery. Nephron 1993;64:165-166.
21. Carlini RG, Obialo CI, Rothstein M: Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am J Hypertens 1993;6:103-107.